www.fdanews.com/articles/148841-sanofi-pulls-leukaemia-drug-ahead-of-possible-ok-for-lemtrada
Sanofi Pulls Leukaemia Drug Ahead of Possible OK for Lemtrada
August 20, 2012
Sanofi's rare disease unit Genzyme is pulling leukaemia drug Campath to prepare for its launch under a different dosage and as a multiple sclerosis treatment that will be branded as Lemtrada.
Yahoo! Finance
Yahoo! Finance